Microbial changes from bariatric surgery alters glucose-dependent insulinotropic polypeptide and prevents fatty liver disease

ABSTRACTBariatric surgery remains a potent therapy for nonalcoholic fatty liver disease (NAFLD), but its inherent risk and eligibility requirement limit its adoption. Therefore, understanding how bariatric surgery improves NAFLD is paramount to developing novel therapeutics. Here, we show that the m...

Full description

Bibliographic Details
Main Authors: Tien S. Dong, William Katzka, Julianne C. Yang, Candace Chang, Nerea Arias-Jayo, Venu Lagishetty, Anna Balioukova, Yijun Chen, Erik Dutson, Zhaoping Li, Emeran A. Mayer, Joseph R. Pisegna, Claudia Sanmiguel, Jonathan P. Jacobs
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Gut Microbes
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19490976.2023.2167170